🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Outcomes After Acute Pulmonary Embolism

Recruitingn/aAges any - anyAllInsel Gruppe AG, University Hospital Bern
NCT04355975 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To investigate safety and effectiveness of PE treatment according to the decision of the multi-disciplinary pulmonary embolism response team (PERT) and to define and optimize treatment indications, institutional algorithms and interventional techniques for PE.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Consecutive patients with pulmonary embolism matching the criteria for treatment according to the decision of the PERT. * Written informed consent Exclusion Criteria: * High probability of non-adherence to the follow up requirements
💊

What it tests

  • Not listed
📍

Where

2 sites
University Hospital Bern - Inselspital
Bern, Switzerland
University Hospital Bern
Bern, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy